Session 5: Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer

Learning Objectives:

• Summarize the current guidelines for EC molecular identification, treatment, and management in advanced and metastatic disease
• Evaluate clinical trial data for the safety and efficacy of emerging EC agents and their implication in clinical practice
• Outline strategies to manage EC treatment outcomes and address cultural, racial, and sociodemographic disparities in EC risk and care